- $207.15bn
- $252.62bn
- $36.75bn
- 96
- 42
- 94
- 92
REG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230726_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230726_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230726_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230725_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230725_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230725_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230725_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230724_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230724_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230724_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230724_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
Announcement